Skip to content

Rives Technique Versus Lichtenstein Repair for Primary Inguinal Hernia

Randomized Clinical Trial of Rives Technique Versus Lichtenstein Repair for Primary Inguinal Hernia

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03488342
Enrollment
600
Registered
2018-04-05
Start date
2015-09-30
Completion date
2018-11-30
Last updated
2018-04-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary Inguinal Hernia

Keywords

Rives technique, Lichtenstein repair

Brief summary

Lichtenstein technique, inserting a mesh over the inguinal cord in the neurological plane, is considered the standard of inguinal hernia repair, but it has 4% recurrence and 12% chronic postoperative pain. Rives technique inserts the mesh in the preperitoneal space behind the neurological plane and the muscular plane, thus better fulfilling the principle of hydrostatics.

Detailed description

These techniques have not been compared randomly for assessment of chronic pain, postoperative complications and recurrences

Interventions

PROCEDURERepair for primary inguinal hernia

Repair for primary inguinal hernia

Sponsors

Hospital Siberia-Serena
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Masking description

Double (Participant, Investigator)

Intervention model description

randomized,controlled and double-blind study

Eligibility

Sex/Gender
ALL
Age
18 Years to 93 Years
Healthy volunteers
No

Inclusion criteria

Men or women aged between 18 and 93 years (inclusive) at the time of the first screening visit. They must provide signed written informed consent and agree to comply the study protocol

Exclusion criteria

Refusal to give informed consent. Refusal to participate giant inguinal hernias

Design outcomes

Primary

MeasureTime frameDescription
Evaluate postoperative complications of pain7 daysThe patients are clinically reviewed in the office within 7 days of discharge (pain is evaluated at rest and with movement (standing up, sitting down, and walking), using a VAS (visual analogue scale). Using a ruler, the score is determined by measuring the distance (mm) on the 10-cm line between the no pain anchor and the patient's mark, providing a range of scores from 0-100. A higher score indicates greater pain intensity. Based on the distribution of pain VAS scores in post- surgical patients, the following cut points on the pain VAS have been recommended: no pain (0-4 mm), mild pain(5-44 mm), moderate pain (45-74 mm), and severe pain (75-100 mm)

Secondary

MeasureTime frameDescription
Evaluate the chronic pain1 yearThe patients are reviewed clinically by the service's surgeons again after a year. If pain is found, this is evaluated as being with movement, spontaneous, episodic, or constant in nature, and measured with a VAS. The patients are clinically reviewed in the office: pain is evaluated at rest and with movement (standing up, sitting down, and walking), using a VAS (visual analogue scale). Using a ruler, the score is determined by measuring the distance (mm) on the 10-cm line between the no pain anchor and the patient's mark, providing a range of scores from 0-100. A higher score indicates greater pain intensity. Based on the distribution of pain VAS scores in post- surgical patients, the following cut points on the pain VAS have been recommended: no pain (0-4 mm), mild pain(5-44 mm), moderate pain (45-74 mm), and severe pain (75-100 mm)
Evaluate the recurrences1 yearThe patients are reviewed clinically by the service's surgeons again after a year. The inguinal region is examined. A mass, reducible or otherwise, is regarded as a recurrence.

Countries

Spain

Contacts

Primary ContactEnrique Javier Grau Talens, PhD
ejgtalens@yahoo.es+34616182400
Backup ContactJosé Jacob Motos Micó, MD
jacob_motos@hotmail.com+34633257986

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026